Production (Stage)
PDS Biotechnology Corporation
PDSB
$1.69
$0.138.33%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -8.49M | -7.95M | -10.73M | -8.33M | -10.60M |
| Total Depreciation and Amortization | 15.10K | 15.10K | 15.10K | 15.10K | 14.40K |
| Total Amortization of Deferred Charges | 272.60K | 297.80K | 305.10K | 283.80K | 270.20K |
| Total Other Non-Cash Items | 1.46M | 1.64M | 1.78M | 2.06M | 1.63M |
| Change in Net Operating Assets | -2.29M | -2.24M | 628.40K | -2.89M | -1.25M |
| Cash from Operations | -9.03M | -8.23M | -8.00M | -8.86M | -9.94M |
| Capital Expenditure | -- | 0.00 | 0.00 | -29.00K | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | 0.00 | 0.00 | -29.00K | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -3.14M | -3.14M | -14.10K | -13.80K | -13.50K |
| Issuance of Common Stock | 7.30M | 3.31M | 31.30K | 0.00 | 20.03M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 3.16M | -- | -- | -- | -- |
| Cash from Financing | 7.32M | 172.80K | 17.20K | -13.80K | 20.01M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.71M | -8.06M | -7.98M | -8.90M | 10.07M |